Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04306367
Title Study of Pembrolizumab and Olaparib in Bile Duct Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Georgetown University
Indications

intrahepatic cholangiocarcinoma

cholangiocarcinoma

gallbladder cancer

Therapies

Olaparib + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.